Estrogen Replacement Therapy
"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
|Estrogen Replacement Therapy
- Estrogen Replacement Therapy
- Estrogen Replacement Therapies
- Replacement Therapies, Estrogen
- Therapies, Estrogen Replacement
- Therapy, Estrogen Replacement
- Replacement Therapy, Estrogen
- Estrogen Replacement
- Estrogen Replacements
- Replacements, Estrogen
- Replacement, Estrogen
Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy".
Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy".
This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles.
The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Menopause. 2023 01 01; 30(1):28-36.
Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS). Menopause. 2021 07 26; 28(10):1108-1116.
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. Menopause. 2021 05 03; 28(6):610-618.
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk. J Natl Cancer Inst. 2017 09 01; 109(9).
Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study. Menopause. 2016 Feb; 23(2):150-7.
Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Oncol Rep. 2016 Feb; 35(2):825-32.
Insights from the Women's Health Initiative: individualizing risk assessment for hormone therapy decisions. Semin Reprod Med. 2014 Nov; 32(6):433-7.
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials. Menopause. 2013 Mar; 20(3):254-60.
Dose-response effect of 40 weeks of resistance training on bone mineral density in older adults. Osteoporos Int. 2011 Jan; 22(1):179-86.
Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol. 2009 Dec 20; 27(36):6135-43.